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Abstract 
Sporadic inclusion body myositis (sIBM) is a late onset disorder of unkown aetiology. Mitochondrial changes such as cytochrome oxidase 
deficient fibres are a well recognised feature and mitochondrial DNA (mtDNA) deletions have also been reported, but not consistently. 
Since mtDNA deletions are not present in all cases, we investigated whether other types of mtDNA abnormality were responsible for the 
mitochondrial changes. We studied 9 patients with sIBM. To control for fibre loss or replacement with inflammatory cells, we compared 
sIBM patients with necrotising myopathy ( n = 4) as well as with healthy controls. Qualitative anlysis for mtDNA deletions and quantitative 
measurement of mtDNA copy number showed that muscle from patients with sIBM contained on average 67% less mtDNA than healthy 
controls ( P = 0.001). The level of mtDNA was also significantly depleted in sIBM when compared to necrotising myopathy. No significant 
difference in copy number was seen in patients with necrotising myopathy compared to controls. Deletions of mtDNA were present in 4 
patients with sIBM, but not all. Our findings suggest that mtDNA depletion is a more consistent finding in sIBM, and one that may be 
implicated in the pathogenesis of the disease. 
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. 
( http://creativecommons.org/licenses/by/4.0/ ) 






















w  1. Introduction 
Sporadic inclusion body myositis (sIBM) is a
late-onset muscle disease of unknown aetiology [1] .
Patients manifest slowly progressive weakness and
atrophy that characteristically affects specific muscle
groups[1]. The disorder is considered the most common
acquired myopathy in the middle-aged and elderly
[2] with estimates of prevelance between 3.3 and 5.1
per 100,000 [2,3] . Although classified with the inflammatory
myopathies, immunomodulatory treatments have been
disappointing in controlling disease progression. Patients with∗ Corresponding author at: Department of Neurology, Haukeland University 
Hospital, 5021 Bergen, Norway. 
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( http://creativecommons.org/licenses/by/4.0/ ) o-existent rheumatological diseases such as Sjogrens
yndrome or systemic lupus erythematosus, or younger
atients with accelerated disease course, may respond to
mmunomodulatory therapy [2] , but evidence suggests the
enefit is only short-term [4] . The mainstay of treatment
emains non-pharmacological and supportive [5] . 
Muscle biopsy changes in sIBM include lymphocytic
nfiltrates in non-vacuolated muscle fibres, vacuolar
egeneration and the deposition of proteins such as beta
myloid. This, together with the lack of response to
mmunosuppressive treatment, [6] has raised questions as to
hether sIBM is primarily a degenerative disease and not an
nflammatory one [7] . Interestingly, several cases of sIBM
ave also been linked to retroviral infections [1] . 
Mitochondrial abnormalities in sIBM are well known
8] and include loss of cytochrome c oxidase activity,
he presence of ragged-red fibres, accumulation of deletedss article under the CC BY license. 











































































































f  tDNA [9 , 10] and abnormal mitophagy [7] . Deletions of
tDNA are reported to accumulate in COX negative fibres
9 , 11] and patients with the highest numbers of COX negative
bres also appear to have a higher proportion of deletion [10] .
t is also reported that there is a greater degree of lymphocytic
nd macrophage infiltration in sIBM muscle fibres with
ore respiratory chain dysfunction [11] . MtDNA deletions
n sIBM are similar to those seen in normal aging and in
utosomally inherited external opthalmoplegia suggesting a
imilar mechanism [12] . There are also rare reports of mtDNA
epletion and dysregulation of Krebs cycle and respiratory
hain proteins [13] and variants in nuclear mitochondrial
enes such as POLG and RRM2B have been recorded [10] . 
While there is considerable evidence of mitochondrial
ysfunction and especially mtDNA abnormalities in sIBM,
tDNA deletions have not been seen in all patients [8] . Since
tDNA is a multicopy genome, we asked whether the absence
f qualitative abnormalities such as deletions simply reflected
he presence of other changes in this genome namely the
uantitative change of mtDNA depletion. 
. Patients and methods 
Nine Norwegian patients with clinically and histologically
stablished sIBM were studied. All patients were over 55
ears of age at diagnosis and all had symptoms for at least 6
onths. None of the patients was on treatment for their sIBM.
iagnositic muscle biopsy was taken from either quadriceps
r tibialis anterior, snap frozen in isopentane, cooled in
iquid nitrogen and kept at −80 °C until use. Histological and
istochemical studies were performed as previously [14] . To
ontrol for the effects of inflammation and muscle fibre loss,
e also studied four patients of similar age with late onset
ecrotising myopathy in which the evolution or pattern of
eakness or biopsy were suggestive of sIBM. These patients
ere suspected of having statin induced myopathy. Eight
ontrols, whose biopsy was taken for diagnostic purposes,
ut who subsequently were found not to have muscle disease,
ere used for comparison. The study was approved by our
ocal ethical committee (2017/1730). 
DNA extraction was performed with a QIamp DNA Mini
it DNA (Qiagen) according to the manufacturer’s protocol.
e performed long PCR using primers that produce ∼8 kb
roduct, as previously described [15] . Relative quantification
f mtDNA copy-number and major arc deletions was
erformed by qPCR as described previously using a triplex
eaction to detect mtDNA genes ND1, ND4 and the single
opy, nuclear gene APP . Relative mtDNA copy number and
eletion fraction were calculated from the ratio of ND1/APP
nd ND4/ND1 respectivelly [15] . 
A Kruskall-Wallis test was used to compare the relative
tDNA copy number (ND1/APP ratio) between sIBM,
ecrotising myopathy and control groups. All data is
llustrated as (mean ± SEM). Individual Mann–Whitney tests
ere performed to compare relative mtDNA copy number
etween each pair. Prism 7.0 was utilised for statistical
nalysis and to create graphs (GraphPad Software, La Jollaalifornia USA). Error bars in graphs represent SEM.
o assess whether demographics (age, gender) or muscle
trophy had a significant effect on mtDNA copy number
easurements, we performed linear multiple regression in
PSS (v25, IBM). In all cases, P < 0.05 was considered
tatistically significant. 
. Results 
All sIBM patients had asymmetric finger flexor weakness,
uadriceps femoris weakness, wrist and hip flexor weakness.
able 1 shows the histological features of the nine patients
ith sIBM and four patients with necrotising myopathy.
haracteristic histopathological features of sIBM were 
resent: rimmed vacuoles were present in eight out of nine
atient biopsies with sIBM. Eight of nine patients also showed
onsiderable inflammation while one patient only showed
nfiltration of a few scattered immune cells. The presence
f CD8 + ve T cells was the predominant inflammatory cell
opulation. Four of nine sIBM patients had large numbers of
OX-negative fibres, but as can be seen in the table, there
s no correlation between the number of COX negative fibres
nd disease duration. 
Long PCR showed evidence of multiple mtDNA deletions
n four of the nine sIBM patients (data not shown), although
his was not confirmed on qPCR, which showed a normal
D4/ND1 ratio for all samples. No deletions were seen in
ontrols or patients with necrotising myopathy. 
MtDNA quantification ( Fig. 1 ) showed significant mtDNA
epletion in all patients with sIBM with on average 67%
ower mtDNA copy number compared with healthy controls
 P = 0.001). Patients with necrotising myopathy showed a
rend toward lower mtDNA copy number, but this was not
tatistically significant ( P = 0.23) ( Fig. 1 ). 
Linear regression analysis showed no significant 
ssociation between the degree of mtDNA depletion and
atient gender ( P = 0.1), age ( P = 0.2) or severity of muscle
trophy ( P = 0.2). 
. Discussion 
Our results confirm significant mtDNA abnormalities in
IBM, however, in contrast to earlier studies [9] , we found
he major defect to be a decrease in mtDNA copy number
i.e. depletion). While long PCR suggested the presence
f mtDNA deletions in four of nine patients, these were
ot detected by the ND4/ND1 qPCR assay suggesting they
ere either at very low levels ( < 10%), or not localized
n the major arc. Since diseased muscle can contain fewer
uscle fibres and significant numbers of other cell types
uch as inflammatory cells that have lower mtDNA content,
e used necrotising myopathy to control for these factors.
uscle from patients with necrotising myopathy showed
 trend for slightly lower levels of mtDNA compared to
ontrols, but this was not statistically significant. These results
uggest that changes in cellular composition were not a major
actor in our analyses. Further, we looked at the correlation
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Table 1 
Histological features of sIBM and necrotising myopathy muscle biopsies. 













CD4 CD8 CD68 CD45 
sIBM 
1 M 57 6 Q Yes + Yes 2 Yes 
2 F 76 8 Q Yes ( + ) + ( + ) + Yes 12 
3 F 74 8 TA Yes ( + ) + ( + ) + Yes 1 Yes Vacuoles with 
myelin figures 
4 M 61 4 Q Yes Yes 15 
5 M 72 5 TA Yes + + + + Yes 20 Yes Vacuoles with 
myelin figures 
6 M 67 8 TA Yes ( + ) + ( + ) + Yes 33 Yes Vacuoles with 
myelin figures, 
cores 
7 M 78 12 Q Yes ( + ) ( + ) + + Yes 0 Yes Vacuoles with 
myelin figures, 
cores 
8 F 69 12 Q Yes ( + ) + + + No 12 Yes Core like 
9 M 71 3 TA Little ( + ) Yes 0 Yes 
Necrotising myopathy 
10 M 64 3 Q Yes ( + ) + ( + ) + No 0 Yes 
11 F 67 1 Q No No No 
12 M 62 1 Q Yes – + + + No 0 Yes No changes 
13 F 84 0.5 Q Some – ( + ) ( + ) ( + ) No 2 Yes Myelin figures 
( + ) = few scattered cells. + = substantial infiltration of immune cells. Q = quadriceps. TA = tibialis anterior. MHC1 = major histocompatibility locus 1. COX 


























































b  between mtDNA depletion and age, degree of muscle atrophy
and gender. While our sample size is small, we found
no association between these parameters and the degree of
depletion. 
Deletions of mtDNA of sIBM patients were first identified
in muscle using in-situ hybridisation [9] ; this was later
confirmed using PCR based techniques [16] . Single fibre
analysis [11] showed that 55% of COX deficient fibres
harboured deletions and low levels were also present in
respiratory competent cells from the same patients. In
a subsequent study [17] , the same authors showed that
individual fibres contained a clonally expanded species of
a mtDNA rearrangement, and in some cases more than one
type of rearrangement (deletion and duplication). PCR-based
techniques do not allow accurate quantification, and many of
these rearranged mtDNA molecules are present at low levels
raising questions as to their biological significance. More
importantly, we have recently shown that the presence of DAB
interferes with mtDNA amplification introducing a significant
bias in the estimation of mitochondrial DNA copy number
and deletion levels between DAB-positive and -negative fibers
[18] . 
The absence of mtDNA deletions in sIBM has been noted
previously [8] . This study used Southern blotting to quantify
mtDNA and while this technique may be less sensitive than
PCR, it does detect deletions that are present at clinically
significant levels. Depletion of skeletal muscle mtDNA in
sIBM has also been reported in one earlier study [13] . These
authors described a mean loss of 36% mtDNA compared
with normal controls, however, no disease control group wasncluded. Further, only 57% of the patients had mtDNA
eletions, although in these, depletion appeared more severe.
nterestingly, this study also suggested lower mtDNA copy
umber in blood cells. In comparison, our study showed
 significant mtDNA depletion in skeletal muscle with an
verage loss of around 67% compared to control. We also
howed that the presence of mtDNA deletion was less than
0%. 
While we cannot exclude the presence of low levels
f mtDNA deletions in individual fibres, particularly COX
eficient fibres, our findings suggest they are not necessarily
he hallmark of sIBM. Sporadic IBM is a late onset
isease, raising the possibility that the presence of mtDNA
bnormalities is an ageing phenomenon and not a disease
elated change. Age appears more strongly associated with
tDNA deletions [19] than depletion, and in other tissues
uch as the substantia nigra, increasing levels of mtDNA
eletions appear to induce a compensatory increase in mtDNA
opy number in non-diseased individuals [18] . An age-related
ncrease in both mtDNA deletions and depletion has been
dentified in paraspinal muscles [20] . In this study, the
umber of COX deficient fibres increased with age and single
bre studies showed that these could either contain clonally
xpanded mtDNA deletions or depletion. The possibility that
ur findings are simply age-related cannot, therefore, be
xcluded. 
If the changes in mtDNA are not simply age-related,
hat is the underlying mechanism and why do some patients
ave deletions while others have depletion and others have
oth? The combination of multiple deletions and depletion is
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Fig. 1. mtDNA analysis in skeletal muscle using relative qPCR 
quantification. (A) mtDNA deletion assessement by comparison of ND4 
(commonly deleted) and ND1 (rarely deleted) amplification against the 
nuclear gene APP . There is no significant difference in the ND4/ND1 
ratio between sIBM, controls or necrotizing myopathy patients. Results 
are compared by Kruskall–Wallis test ( P = 0.785). Error bars show SEM. 
(B) Relative quantification of mtDNA ( ND1 ) against the nuclear gene 
APP . Patients with sIBM show significant mtDNA depletion compared to 
controls ( P = 0.001). Patients with necrotizing myopathy show no significant 
difference from controls ( P = 0.23) or sIBM ( P = 0.14). Mean ND1/APP 
ratio ± SEM for sIBM: 0.35 ± 0.06; necrotising myopathy: 0.74 ± 0.26; 
healthy controls: 1.07 ± 0.12. Results are compared by Kruskall–Wallis test. 


































































imilar to that found in the presence of mutations in genes
nvolved in mtDNA homeostasis. For example, mutations
n the catalytic subunit of polymerase gamma can cause
oth mtDNA deletion and depletion and this varies from
issue to tissue [21] . Oldfors and colleagues [16] looked in
IBM patients for mutations in POLG as wells as SLC25A4
ANT1) and TWNK (Twinkle, C10orf2), but found none.
n a follow up study this group examined a larger panel
f genes including - C10orf2 (Twinkle), DNA2, MGME1,
PA1, POLG2, RRM2B, SLC25A4 ( ANT1 ) and TYMP [10] .
hey found several variants in POLG which are likely
olymorphisms and no association with 10/22 CAG repeats.
ariants in RRM2B and TWNK were also identified, but the
uggestion that sIBM may be secondary to abnormalities in
enes involved in mtDNA homeostasis has yet to be verified.
Sporadic IBM is a common disorder with a high prevalence
n Norway (Dobloug 2015). Currently, the aetiology remains
nknown, but growing evidence supports a mechanistic
ole for mitochondria in disease pathogenesis. Whateverhe proximal event, mtDNA deletion/depletion will itself
dversely affect energetic cells such as muscle and even if
hese changes are not the primary cause of sIBM, they are
ighly likely to play a role in disease development. The
resence of mtDNA depletion in white blood cells [13] is
 potential biomarker that, in the light of our studies, should
erhaps be investigated further. 
. Conclusion 
We have demonstrated the presence of significant mtDNA
epletion in sIBM, with varying degrees of mtDNA deletions.
his is a novel finding. The absence of mtDNA depletion
n necrotising myopathy samples suggests that this finding
s specific for sIBM. However, we do not imply that mtDNA
amage is an aetiological factor of sIBM, but may accumulate
s the disease progresses. Clearly, the role of mtDNA damage
n the pathogenesis of sIBM remains to be elucidated and
hould be further investigated. 
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